Prestige Consumer Healthcare (PBH) Barclays 17th Annual Global Consumer Staples Conference summary
Event summary combining transcript, slides, and related documents.
Barclays 17th Annual Global Consumer Staples Conference summary
22 Jan, 2026Brand portfolio and category insights
Operates in women's health, cough/cold, GI, and ear/eye care, focusing on unique brand positioning rather than broad categories.
Key brands include Monistat, Summer's Eve, Clear Eyes, TheraTears, and Debrox, each serving distinct consumer needs.
Summer's Eve repositioning toward beauty/daily hygiene was less successful, but Monistat and eye care brands show stable growth.
GI brands like Dramamine and Gaviscon are performing well, with ongoing product innovation.
Growth profile and business evolution
Shifted from household cleaning to a focused consumer healthcare portfolio since 2010, with major acquisitions and divestitures.
Achieved 2%-3% organic CAGR over the past five years, supported by innovation and changing consumer habits post-COVID.
Growth during inflation was driven mostly by price, not volume loss, differentiating from other CPGs.
Competitive landscape and category growth
Peers with broader geographic reach or beauty/personal care focus may achieve higher growth rates.
International business expected to grow 5%-6% long-term, with eye care as a key North American growth driver.
Eye care growth fueled by increased screen time and greater consumer awareness of dry eye treatment.
Latest events from Prestige Consumer Healthcare
- Q3 revenue fell 2.4% but free cash flow and share buybacks remained strong amid supply challenges.PBH
Q3 20265 Feb 2026 - Q1 revenue beat expectations, cash flow rose, and FY2025 outlook was reaffirmed.PBH
Q1 20252 Feb 2026 - Brand investment, innovation, and disciplined capital allocation drive growth amid supply chain recovery.PBH
Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference1 Feb 2026 - Brand innovation, e-commerce growth, and strong cash flow drive long-term value creation.PBH
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q2 FY25 saw $283.8M revenue, strong international growth, and robust free cash flow.PBH
Q2 202516 Jan 2026 - Diversified brands, innovation, and e-commerce drive growth; supply and margin recovery underway.PBH
28th Annual Needham Growth Conference Virtual13 Jan 2026 - Strong cash flow, resilient margins, and targeted pricing drive growth and stability.PBH
27th Annual ICR Conference 2025,10 Jan 2026 - Disciplined M&A, innovation, and e-commerce drive growth and strong free cash flow outlook.PBH
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Record Q3 results, raised FY25 outlook, strong cash flow, and reduced leverage.PBH
Q3 202517 Dec 2025